Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,213,970
-$1,493,078 QoQ
Shares Held
216,527
-9.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#588
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOWE BROCKENBROUGH & CO INC holds $62,097,620 across 10 Drug Manufacturers - General names. PFE ranks #6 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,660 | $12,104,210 | |
| 2 | MRK |
Merck & Co., Inc.
|
91,716 | $11,785,506 | |
| 3 | LLY |
ELI LILLY & Co
|
8,214 | $9,852,118 | |
| 4 | AMGN |
Amgen Inc
|
26,947 | $9,758,047 | |
| 5 | ABBV |
AbbVie Inc.
|
29,181 | $7,343,106 | |
| 6 | PFE |
Pfizer Inc
This page
|
216,527 | $5,213,970 | |
| 7 | NVS |
Novartis AG
|
13,636 | $2,137,033 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
32,635 | $1,880,428 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,213,970 | 216,527 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $6,707,048 | 238,855 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,222,152 | 209,725 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,260,957 | 206,474 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $4,617,283 | 190,482 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,922,573 | 194,261 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,217,686 | 158,978 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $7,590,730 | 262,292 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $7,895,088 | 282,169 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,676,871 | 276,644 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,356,478 | 255,522 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,641,846 | 260,532 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,247,087 | 197,576 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,639,751 | 162,739 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,217,922 | 160,381 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,908,347 | 157,869 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $8,758,169 | 167,045 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $8,515,595 | 164,489 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $9,729,963 | 164,775 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,072,134 | 164,430 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,383,275 | 163,005 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,780,858 | 159,560 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,765,513 | 156,629 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $5,507,306 | 150,063 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,843,234 | 148,111 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,807,930 | 147,302 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||